E. Ohman J or Asset Management AB Lowers Position in HCA Healthcare, Inc. (NYSE:HCA)

E. Ohman J or Asset Management AB lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 12.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,893 shares of the company’s stock after selling 1,137 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in HCA Healthcare were worth $2,727,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. Congress Wealth Management LLC DE raised its stake in HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock valued at $312,000 after buying an additional 34 shares during the last quarter. Evergreen Private Wealth LLC raised its stake in HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock valued at $3,838,000 after buying an additional 35 shares during the last quarter. Prairie Wealth Advisors Inc. raised its stake in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after buying an additional 40 shares during the last quarter. Whittier Trust Co. raised its stake in HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock valued at $359,000 after buying an additional 41 shares during the last quarter. Finally, Coldstream Capital Management Inc. increased its holdings in shares of HCA Healthcare by 1.3% in the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company’s stock worth $1,042,000 after purchasing an additional 44 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.8%

Shares of HCA stock opened at $384.52 on Friday. The company has a market cap of $92.51 billion, a price-to-earnings ratio of 17.50, a PEG ratio of 1.10 and a beta of 1.49. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a fifty day moving average price of $355.28 and a 200-day moving average price of $331.72. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. HCA Healthcare’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.36 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.75%. HCA Healthcare’s dividend payout ratio is currently 12.81%.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Guggenheim initiated coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating for the company. Barclays set a $416.00 target price on HCA Healthcare and gave the stock an “overweight” rating in a report on Monday, June 2nd. Robert W. Baird reaffirmed a “neutral” rating and issued a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, Baird R W cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $388.80.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.